This message was sent to ##Email##
|
|
|
|
|
| ACS CANCER PROGRAMS UPDATES |
| CoC Plenary Session to focus on new surgical standards, NCDB changes and more
|
    |
If you are attending the American College of Surgeons (ACS) Clinical Congress or are from a Commission on Cancer (CoC)-accredited cancer program in the Bay area, join us at the CoC Plenary Session: New Standards — An Open Forum on Sunday, October 27 from 1:00 to 5:00 pm at the Hilton San Francisco Union Square Hotel, located at 333 O’Farrell Street, San Francisco, CA. This meeting will include presentations on quality of care and CoC accreditation in rural America; presentations by select CoC member organizations, including the American Cancer Society; an update on changes to the National Cancer Database (NCDB); and what you need to know about the new CoC standards.
CoC members, state chairs and cancer liaison physicians were sent a separate registration link and should contact Andrea Scrementi to register at ascrementi@facs.org. All others interested in attending this meeting should register by Tuesday, October 15. We can accommodate individuals on a first come, first served basis until we reach our meeting room capacity. If you have questions, please e-mail ascrementi@facs.org.
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
| Learn about the latest advances in cancer care at Clinical Congress 2019
|
|
American College of Surgeons (ACS) Cancer Programs will offer a range of educational sessions at the Clinical Congress 2019. Scheduled programming is as follows:
Monday
- Panel Session: Multidisciplinary Management of Breast Cancer
- Panel Session: Clinical Trials in Personalized Medicine in Oncology
Tuesday
- Special Interest Session: Cracking the Code to Clinical Trial Enrollment: How to Start and Who Can Help
- Panel Session: Optimizing Outcomes of Rectal Cancer in 2019
- Panel Session: Gastric and Gastroesophageal Junction Cancer: Latest Advances
- Panel Session: Management of the Nodal Basin in the Melanoma Patient
- Panel Session: Management of Peritoneal Malignancies: Emerging Data in Heated Intraperitoneal Chemotherapy (HIPEC) and Other Strategies
Wednesday
- Panel Session: Immunotherapy in the Treatment of Solid Tumors: Emerging Roles of the Surgeon
- Special Session: Cancer Surgery and Quality of Care Standards
- Meet-the-Expert Session: Improving Outcomes in Bladder Cancer Surgery: Important Advances in Care
- Commission on Cancer Oncology Lecture: Pancreatic Cancer: Progress and Prospects
- Panel Session: What's New in the Management of Pancreatic Cancer?
Thursday
- 10 Hot Topics in Surgical Oncology
To learn more about ACS Cancer Programs, visit ACS Central in the Moscone Center Exhibit Hall.
| |
SERVICE SHOWCASE | Advertisement
|
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
| September CAnswer Forum Live recording now available
|
|
Did you miss CAnswer Forum LIVE on September 25?
Don’t worry. Access the session recording and download a PDF of the slides from the CAnswer Forum LIVE web page.
Mark December 11 on your calendar, and plan to join us for the next CAnswer Forum LIVE session at 12:00 noon Central. The webinar will address questions for all areas of Cancer Programs activities and the 2020 CoC Standards.
Registration for the December 11 session will open on October 24. Watch The Brief for this announcement.
We look forward to having you join us.
|
Advertisement
|
|
|
|
|
| Download a Breast Cancer Awareness Month poster
|
|
Now that it’s officially Breast Cancer Awareness Month, the National Accreditation Program for Breast Centers (NAPBC) and the CoC encourage programs to promote their accreditation status to staff, patients and the community throughout the month of October. To help with this effort, the NAPBC and the CoC have created a downloadable poster that acknowledges accredited programs’ commitment to the delivery of high-quality care.
Centers solely accredited by the NAPBC
- Log in to the NAPBC Portal.
- Open the Resources Tab.
- Scroll to the bottom of the page and click on the NAPBC Marketing Resources link.
- Download and print the Breast Cancer Awareness Month Poster.
- Download the artwork for a poster and banner stand to help you promote your NAPBC accreditation.
Programs that are accredited by the CoC solely and/or by both the CoC and NAPBC:
- Log in to CoC Datalinks.
- Click on the CoC-Accredited Cancer Program Marketing Materials link.
- Download and print the Breast Cancer Awareness Month Poster.
- Download the artwork for a poster and banner stand to help you promote your CoC accreditation.
 |
|
VTI’s Remotely Operated Suction Irrigation System (or “ROSI”) presents a new paradigm in suction and irrigation for robot-assisted procedures. The ROSI system gives the console surgeon complete control of suction and irrigation capabilities.
|
|
| Webinar reviews best practices in diagnosis and treatment of inflammatory breast cancer
|
|
In a recent webinar on inflammatory breast cancer (IBC), hosted by the NAPBC Advocacy and Education Dissemination committees, Beth Overmoyer, MD, FACP, recommended that physicians move quickly to refer patients presenting with breast inflammation for breast imaging and surgical referral.
“Although uncommon, IBC accounts for a disproportionate percentage of cancer-related deaths,” said Dr. Beth Overmoyer, director of the Inflammatory Breast Cancer Program at Dana Farber Cancer Institute. “There is often a delay in diagnosis arising from health care professionals not including IBC as part of the differential diagnosis of an ‘inflamed’ breast, especially in postmenopausal women.”
In “Best Practices in the Diagnosis and Treatment of Inflammatory Breast Cancer,” Dr. Overmoyer recommended that for postmenopausal women, physicians should refer immediately for breast imaging and evaluation when inflammation is present. For premenopausal women, physicians should prescribe at most one week of antibiotics prior to referral if the symptoms are not completely resolved.
Dr. Overmoyer also urged physicians to remember that treatment options for IBC differ dramatically from those used for locally advanced breast cancer.
“The current criteria for diagnosing IBC does not apply to our current state of the art in 2019,” she said. “A rapid onset of breast changes will identify IBC from locally advanced breast cancer.”
Dr. Overmoyer cited ongoing IBC research, involving both radiation and systemic therapy, as central to future developments in the diagnosis and treatment of the disease.
“The Translational Breast Cancer Research Consortium is spearheading investigations of this disease, trying to understand the local regional aspects of IBC,” she said. “The IBC focus group convened by Susan G. Komen®, the Inflammatory Breast Cancer Research Foundation and the Milburn Foundation is in the process of revising the diagnostic criteria for this disease, which will translate into a greater understanding of its biology.”
Find registration information and instructions to access the recorded webinar online. This educational activity is approved for 1 AMA PRA Category 1 Credits™ by the American College of Surgeons and for 1 CE credit by the National Cancer Registrars Association.
| HEALTH CARE NEWS AND UPDATES |
The New York Times
Public health officials for years have urged Americans to limit consumption of red meat and processed meats because of concerns that these foods are linked to heart disease, cancer and other ills.
But recently, in a remarkable turnabout, an international collaboration of researchers produced a series of analyses concluding that the advice, a bedrock of almost all dietary guidelines, is not backed by good scientific evidence.
READ MORE
Hartford Courant
In breast cancer surgery, taking just a little bit more healthy tissue initially can help patients avoid a return trip to the operating room.
This surgical technique, known as resection of cavity shave margins, has been shown to reduce the rate of cancerous margins of a breast cancer surgical specimen and the need for repeat surgery by half in women undergoing breast conserving surgery. In this technique, surgeons remove additional tissue in the circumference of the cavity left by a partial mastectomy.
READ MORE
News-Medical.Net
University of Texas at Dallas researchers have demonstrated that imaging technology used to map the universe shows promise for more accurately and quickly identifying cancer cells in the operating room.
In a study published in the Sept. 14 edition of the journal Cancers, Dr. Baowei Fei and colleagues showed that hyperspectral imaging and artificial intelligence could predict the presence of cancer cells with 80% to 90% accuracy in 293 tissue specimens from 102 head and neck cancer surgery patients.
READ MORE
Genetic Engineering & Biotechnology News
Semen could be considered a liquid biopsy of the organs of male reproductive system — specifically, of the prostate gland. This is convenient. Semen is, potentially, a source of prostate disease-specific molecules, which are of intense interest because they could lead to better diagnostic tests. If so, semen-based tests could augment or replace the serum prostate-specific antigen (PSA) screen. Although the PSA screen is credited with a significant decrease in deaths due to prostate cancer, it still has serious limitations.
READ MORE
University of Alberta via Medical Xpress
Imagine cancer treatment without chemotherapy, radiation or surgery. Just a small aspirin-like pill.
Sound like magic? That's because it kind of is, according to Khaled Barakat, a University of Alberta biophysicist searching for innovative immunotherapies that could help knock out multiple types of cancer simply by empowering the immune system.
READ MORE
ScienceDaily
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial. This marks a significant advance for prostate cancer treatment, which has lagged behind other common cancers with regard to precision therapy, now the standard of care in breast, ovarian and lung cancers.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the American College of Surgeons Cancer Programs from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The American College of Surgeons and Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
